Cited by

• Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation.

  Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB. Mohamed J, et al. Sultan Qaboos Univ Med J. 2016 May;16(2):e132-41. doi: 10.18295/squmj.2016.16.02.002. Epub 2016 May 15. Sultan Qaboos Univ Med J. 2016. PMID: 27226903 Free PMC article. Review.
• Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.

  Pereira ENGDS, Silvares RR, Flores EEI, Rodrigues KL, Ramos IP, da Silva IJ, Machado MP, Miranda RA, Pazos-Moura CC, Gonçalves-de-Albuquerque CF, Faria-Neto HCC, Tibiriça E, Daliry A. Pereira ENGDS, et al. PLoS One. 2017 Jun 19;12(6):e0179654. doi: 10.1371/journal.pone.0179654. eCollection 2017. PLoS One. 2017. PMID: 28628674 Free PMC article.
• Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease.

  Butscheid M, Hauptvogel P, Fritz P, Klotz U, Alscher DM. Butscheid M, et al. J Clin Pathol. 2007 Apr;60(4):415-8. doi: 10.1136/jcp.2005.032391. Epub 2006 Jun 14. J Clin Pathol. 2007. PMID: 16775125 Free PMC article.
• Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.

  Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Targher G, et al. Diabetologia. 2008 Mar;51(3):444-50. doi: 10.1007/s00125-007-0897-4. Epub 2007 Dec 6. Diabetologia. 2008. PMID: 18058083
• Hepatic stress associated with pathologies characterized by disturbed glucose production.

  Gjorgjieva M, Mithieux G, Rajas F. Gjorgjieva M, et al. Cell Stress. 2019 Jan 28;3(3):86-99. doi: 10.15698/cst2019.03.179. Cell Stress. 2019. PMID: 31225503 Free PMC article. Review.